New therapeutic strategies to treat human cancers expressing mutant p53 proteins

G Blandino, S Di Agostino - Journal of Experimental & Clinical Cancer …, 2018 - Springer
The tumor suppressor p53 plays a critical role to preserve DNA fidelity from diverse insults
through the regulation of cell-cycle checkpoints, DNA repair, senescence and apoptosis …

The rebel angel: mutant p53 as the driving oncogene in breast cancer

D Walerych, M Napoli, L Collavin, G Del Sal - Carcinogenesis, 2012 - academic.oup.com
Breast cancer is the most frequent invasive tumor diagnosed in women, causing over 400
000 deaths yearly worldwide. Like other tumors, it is a disease with a complex …

Mutant p53 on the path to metastasis

Q Tang, Z Su, W Gu, AK Rustgi - Trends in cancer, 2020 - cell.com
Metastasis contributes to the vast majority of cancer-related mortality. Regulatory
mechanisms of the multistep invasion-metastasis cascade are being unraveled. TP53 is the …

A Pin1/mutant p53 axis promotes aggressiveness in breast cancer

JE Girardini, M Napoli, S Piazza, A Rustighi, C Marotta… - Cancer cell, 2011 - cell.com
TP53 missense mutations dramatically influence tumor progression, however, their
mechanism of action is still poorly understood. Here we demonstrate the fundamental role of …

p53-family proteins and their regulators: hubs and spokes in tumor suppression

L Collavin, A Lunardi, G Del Sal - Cell Death & Differentiation, 2010 - nature.com
The tumor suppressor p53 is a central hub in a molecular network controlling cell
proliferation and death in response to potentially oncogenic conditions, and a wide array of …

Cancer stemness: p53 at the wheel

D Ghatak, D Das Ghosh, S Roychoudhury - Frontiers in oncology, 2021 - frontiersin.org
The tumor suppressor p53 maintains an equilibrium between self-renewal and
differentiation to sustain a limited repertoire of stem cells for proper development and …

Understanding wild-type and mutant p53 activities in human cancer: new landmarks on the way to targeted therapies

I Goldstein, V Marcel, M Olivier, M Oren, V Rotter… - Cancer gene …, 2011 - nature.com
Three decades of p53 research have led to many advances in understanding the basic
biology of normal and cancer cells. Nonetheless, the detailed functions of p53 in normal …

[HTML][HTML] Mutant p53 tunes the NRF2-dependent antioxidant response to support survival of cancer cells

K Lisek, E Campaner, Y Ciani, D Walerych, G Del Sal - Oncotarget, 2018 - ncbi.nlm.nih.gov
Abstract NRF2 (NFE2L2) is one of the main regulators of the antioxidant response of the cell.
Here we show that in cancer cells NRF2 targets are selectively upregulated or repressed …

Mutant p53: one, no one, and one hundred thousand

D Walerych, K Lisek, G Del Sal - Frontiers in oncology, 2015 - frontiersin.org
Encoded by the mutated variants of the TP53 tumor suppressor gene, mutant p53 proteins
are getting an increased experimental support as active oncoproteins promoting tumor …

Oncogenic intra-p53 family member interactions in human cancers

M Ferraiuolo, S Di Agostino, G Blandino… - Frontiers in …, 2016 - frontiersin.org
The p53 gene family members p53, p73, and p63 display several isoforms derived from the
presence of internal promoters and alternative splicing events. They are structural homologs …